Literature DB >> 32848271

Staphylococcus aureus Bacteremia: Contemporary Management.

Leny Abraham1, David M Bamberger2.   

Abstract

Staphylococcus aureus bacteremia (SAB) is a serious cause of bloodstream infection associated with significant morbidity and mortality. Complications include deep-seated foci of infection including infective endocarditis, device-associated infection, osteoarticular metastases, pleuropulmonary involvement, and recurrent infection. With the 30-day all-cause mortality being around 20%, a collaborative effort of early Infectious Diseases (ID) consultation and Antimicrobial Stewardship Program (ASP) involvement will show improved SAB outcomes and therapy optimization.1. Copyright 2020 by the Missouri State Medical Association.

Entities:  

Mesh:

Year:  2020        PMID: 32848271      PMCID: PMC7431060     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  29 in total

1.  Antimicrobial therapy for bloodstream infection due to methicillin-susceptible Staphylococcus aureus in an era of increasing methicillin resistance: opportunities for antimicrobial stewardship.

Authors:  Birgir Johannsson; Sarah J Johnson; Erika J Ernst; Susan E Beekmann; Loreen Herwaldt; Daniel J Diekema; Philip M Polgreen
Journal:  Ann Pharmacother       Date:  2012-06-05       Impact factor: 3.154

2.  Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*.

Authors:  M V Larsen; Z B Harboe; S Ladelund; R Skov; J Gerstoft; C Pedersen; C S Larsen; N Obel; G Kronborg; T Benfield
Journal:  HIV Med       Date:  2011-08-07       Impact factor: 3.180

3.  Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia.

Authors:  Bharath Raj Palraj; Larry M Baddour; Erik P Hess; James M Steckelberg; Walter R Wilson; Brian D Lahr; M Rizwan Sohail
Journal:  Clin Infect Dis       Date:  2015-03-25       Impact factor: 9.079

4.  Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs.

Authors:  P A Willcox; B L Rayner; D A Whitelaw
Journal:  QJM       Date:  1998-01

5.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

6.  The value of infectious diseases consultation in Staphylococcus aureus bacteremia.

Authors:  Hitoshi Honda; Melissa J Krauss; Jeffrey C Jones; Margaret A Olsen; David K Warren
Journal:  Am J Med       Date:  2010-05-20       Impact factor: 4.965

Review 7.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.

Authors:  Maria Souli; Felicia Ruffin; Seong-Ho Choi; Lawrence P Park; Shengli Gao; Nicholas Christopoulos Lent; Batu K Sharma-Kuinkel; Joshua T Thaden; Stacey A Maskarinec; Lisa Wanda; Jonathan Hill-Rorie; Bobby Warren; Brenda Hansen; Vance G Fowler
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

9.  Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.

Authors:  Dawn M Sievert; Philip Ricks; Jonathan R Edwards; Amy Schneider; Jean Patel; Arjun Srinivasan; Alex Kallen; Brandi Limbago; Scott Fridkin
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-27       Impact factor: 3.254

10.  Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments.

Authors:  Erin K McCreary; Ravina Kullar; Matthew Geriak; Evan J Zasowski; Khulood Rizvi; Lucas T Schulz; Krista Ouellette; Logan Vasina; Fadi Haddad; Michael J Rybak; Marcus J Zervos; George Sakoulas; Warren E Rose
Journal:  Open Forum Infect Dis       Date:  2019-12-31       Impact factor: 3.835

View more
  1 in total

1.  Regulation of virulence and β-lactamase gene expression in Staphylococcus aureus isolates: cooperation of two-component systems in bloodstream superbugs.

Authors:  Sanaz Dehbashi; Hamed Tahmasebi; Behrouz Zeyni; Mohammad Reza Arabestani
Journal:  BMC Microbiol       Date:  2021-06-25       Impact factor: 3.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.